earnings
confidence high
sentiment positive
materiality 0.75
Veracyte Q2 revenue $130.2M (+14% YoY); raises testing revenue guidance
VERACYTE, INC.
2025-Q2 EPS reported
$0.08
revenue$244,637,000
- Total revenue of $130.2M (+14% YoY); testing revenue of $122.3M (+14%).
- Decipher revenue $76.3M (+24%), volume ~25,500 (+28%); Afirma revenue $43.4M (+5%).
- GAAP net loss $1.0M includes $20.5M impairment; adj. EBITDA $35.8M (27.5% of revenue).
- Cash from operations $33.6M; cash & investments $320.7M at quarter end.
- Raises FY2025 testing revenue guidance to $477-483M (14-15% growth); FY total revenue $496-504M.